Brain 0 5 0 5 B-cancer
tumors 6 12 6 12 I-cancer
of 13 15 13 15 O
all 16 19 16 19 O
World 20 25 20 25 O
Health 26 32 26 32 O
Organization 33 45 33 45 O
( 46 47 46 47 O
WHO 47 50 47 50 O
) 50 51 50 51 O
grades 52 58 52 58 O

Currently 0 9 59 68 O
receiving 10 19 69 78 O
another 20 27 79 86 O
investigational 28 43 87 102 B-treatment
drug 44 48 103 107 I-treatment

Currently 0 9 108 117 O
receiving 10 19 118 127 O
any 20 23 128 131 O
other 24 29 132 137 O
anti 30 34 138 142 B-treatment
- 34 35 142 143 I-treatment
cancer 35 41 143 149 I-treatment
agents 42 48 150 156 I-treatment

Currently 0 9 157 166 O
receiving 10 19 167 176 O
enzyme 20 26 177 183 O
inducing 27 35 184 192 O
anticonvulsants 36 51 193 208 B-treatment

Currently 0 9 209 218 O
receiving 10 19 219 228 O
receiving 20 29 229 238 O
potent 30 36 239 245 B-treatment
CYP3A4 37 43 246 252 I-treatment
( 44 45 253 254 I-treatment
enzyme 45 51 254 260 I-treatment
) 51 52 260 261 I-treatment
inducers 53 61 262 270 I-treatment
or 62 64 271 273 O
inhibitors 65 75 274 284 B-treatment

Extracranial 0 12 285 297 O
solid 13 18 298 303 B-cancer
tumors 19 25 304 310 I-cancer
including 26 35 311 320 O
histiocytoses 36 49 321 334 B-chronic_disease

Fully 0 5 335 340 O
recovered 6 15 341 350 O
from 16 20 351 355 O
acute 21 26 356 361 B-chronic_disease
toxic 27 32 362 367 I-chronic_disease
effects 33 40 368 375 O
of 41 43 376 378 O
all 44 47 379 382 O
prior 48 53 383 388 B-treatment
anti 54 58 389 393 I-treatment
- 58 59 393 394 I-treatment
cancer 59 65 394 400 I-treatment
therapy 66 73 401 408 I-treatment

Karnofsky 0 9 409 418 B-clinical_variable
performance 10 21 419 430 I-clinical_variable
level 22 27 431 436 I-clinical_variable
of 28 30 437 439 O
greater 31 38 440 447 O
than 39 43 448 452 O
or 44 46 453 455 O
equal 47 52 456 461 O
to 53 55 462 464 O
50 56 58 465 467 B-lower_bound
percent 59 66 468 475 I-lower_bound
for 67 70 476 479 O
participants 71 83 480 492 O
who 84 87 493 496 O
are 88 91 497 500 O
greater 92 99 501 508 O
than 100 104 509 513 O
16 105 107 514 516 B-lower_bound
years 108 113 517 522 I-lower_bound
of 114 116 523 525 O
age 117 120 526 529 B-age
at 121 123 530 532 O
the 124 127 533 536 O
time 128 132 537 541 O
of 133 135 542 544 O
screening 136 145 545 554 O

Lansky 0 6 555 561 B-clinical_variable
performance 7 18 562 573 I-clinical_variable
level 19 24 574 579 I-clinical_variable
of 25 27 580 582 O
greater 28 35 583 590 O
than 36 40 591 595 O
or 41 43 596 598 O
equal 44 49 599 604 O
to 50 52 605 607 O
50 53 55 608 610 B-lower_bound
percent 56 63 611 618 I-lower_bound
for 64 67 619 622 O
participants 68 80 623 635 O
who 81 84 636 639 O
are 85 88 640 643 O
less 89 93 644 648 O
than 94 98 649 653 O
or 99 101 654 656 O
equal 102 107 657 662 O
to 108 110 663 665 O
16 111 113 666 668 B-upper_bound
years 114 119 669 674 I-upper_bound
of 120 122 675 677 O
age 123 126 678 681 B-age
at 127 129 682 684 O
the 130 133 685 688 O
time 134 138 689 693 O
of 139 141 694 696 O
screening 142 151 697 706 O

Participants 0 12 707 719 O
must 13 17 720 724 O
have 18 22 725 729 O
had 23 26 730 733 O
a 27 28 734 735 O
histologic 29 39 736 746 O
verification 40 52 747 759 O
of 53 55 760 762 O
malignancy 56 66 763 773 B-cancer
at 67 69 774 776 O
original 70 78 777 785 O
diagnosis 79 88 786 795 O
or 89 91 796 798 O
relapse 92 99 799 806 O

Participants 0 12 807 819 O
with 13 17 820 824 O
any 18 21 825 828 O
of 22 24 829 831 O
the 25 28 832 835 O
following 29 38 836 845 O
tumors 39 45 846 852 B-cancer
who 46 49 853 856 O
have 50 54 857 861 O
experienced 55 66 862 873 O
relapse 67 74 874 881 O
following 75 84 882 891 O
front 85 90 892 897 B-treatment
- 90 91 897 898 I-treatment
line 91 95 898 902 I-treatment
therapy 96 103 903 910 I-treatment

Patients 0 8 911 919 O
must 9 13 920 924 O
be 14 16 925 927 O
off 17 20 928 931 O
of 21 23 932 934 O
cannabis 24 32 935 943 B-treatment
oil 33 36 944 947 I-treatment
for 37 40 948 951 O
3 41 42 952 953 B-upper_bound
days 43 47 954 958 I-upper_bound
prior 48 53 959 964 I-upper_bound
to 54 56 965 967 O
enrollment 57 67 968 978 O

Patients 0 8 979 987 O
with 9 13 988 992 O
neuroblastoma 14 27 993 1006 B-cancer
who 28 31 1007 1010 O
do 32 34 1011 1013 O
not 35 38 1014 1017 O
have 39 43 1018 1022 O
measurable 44 54 1023 1033 O
disease 55 62 1034 1041 O
but 63 66 1042 1045 O
have 67 71 1046 1050 O
metaiodobenzylguanidine 72 95 1051 1074 B-treatment
( 96 97 1075 1076 I-treatment
MIBG+ 97 102 1076 1081 I-treatment
) 102 103 1081 1082 I-treatment
evaluable 104 113 1083 1092 O
disease 114 121 1093 1100 O

Random 0 6 1101 1107 O
or 7 9 1108 1110 O
fasting 10 17 1111 1118 B-clinical_variable
blood 18 23 1119 1124 I-clinical_variable
glucose 24 31 1125 1132 I-clinical_variable
within 32 38 1133 1139 O
the 39 42 1140 1143 O
upper 43 48 1144 1149 O
normal 49 55 1150 1156 O
limits 56 62 1157 1163 O
for 63 66 1164 1167 O
age 67 70 1168 1171 B-age

Serum 0 5 1172 1177 B-clinical_variable
triglyceride 6 18 1178 1190 I-clinical_variable
level 19 24 1191 1196 I-clinical_variable
≤300 25 29 1197 1201 O
mg 30 32 1202 1204 I-upper_bound
/ 32 33 1204 1205 I-upper_bound
dL 33 35 1205 1207 I-upper_bound

The 0 3 1208 1211 O
use 4 7 1212 1215 O
of 8 10 1216 1218 O
cannabis 11 19 1219 1227 B-treatment
oil 20 23 1228 1231 I-treatment
is 24 26 1232 1234 O
prohibited 27 37 1235 1245 O
during 38 44 1246 1252 O
the 45 48 1253 1256 O
first 49 54 1257 1262 O
2 55 56 1263 1264 O
cycles 57 63 1265 1271 O
of 64 66 1272 1274 O
this 67 71 1275 1279 O
protocol 72 80 1280 1288 O

Uncontrolled 0 12 1289 1301 B-chronic_disease
infection 13 22 1302 1311 I-chronic_disease

Women 0 5 1312 1317 B-gender
who 6 9 1318 1321 O
are 10 13 1322 1325 B-pregnancy
currently 14 23 1326 1335 I-pregnancy
pregnant 24 32 1336 1344 I-pregnancy

diffuse 0 7 1345 1352 B-cancer
intrinsic 8 17 1353 1362 I-cancer
pontine 18 25 1363 1370 I-cancer
glioma 26 32 1371 1377 I-cancer
( 33 34 1378 1379 I-cancer
DIPG 34 38 1379 1383 I-cancer
) 38 39 1383 1384 I-cancer

optic 0 5 1385 1390 B-cancer
pathway 6 13 1391 1398 I-cancer
gliomas 14 21 1399 1406 I-cancer

participants 0 12 1407 1419 O
with 13 17 1420 1424 O
pineal 18 24 1425 1431 B-cancer
tumors 25 31 1432 1438 I-cancer
and 32 35 1439 1442 O
elevations 36 46 1443 1453 O
of 47 49 1454 1456 O
serum 50 55 1457 1462 O
or 56 58 1463 1465 O
cerebrospinal 59 72 1466 1479 O
fluid 73 78 1480 1485 O
( 79 80 1486 1487 O
CSF 80 83 1487 1490 O
) 83 84 1490 1491 O
alpha 85 90 1492 1497 O
- 90 91 1497 1498 O
fetoprotein 91 102 1498 1509 O
( 103 104 1510 1511 O
AFP 104 107 1511 1514 O
) 107 108 1514 1515 O
or 109 111 1516 1518 O
beta 112 116 1519 1523 O
- 116 117 1523 1524 O
human 117 122 1524 1529 O
chorionic 123 132 1530 1539 O
gonadotropin 133 145 1540 1552 O
( 146 147 1553 1554 O
beta 147 151 1554 1558 O
- 151 152 1558 1559 O
HCG 152 155 1559 1562 O
) 155 156 1562 1563 O

participants 0 12 1564 1576 O
with 13 17 1577 1581 O
tumors 18 24 1582 1588 B-cancer
that 25 29 1589 1593 O
carry 30 35 1594 1599 O
a 36 37 1600 1601 O
poor 38 42 1602 1606 O
prognosis 43 52 1607 1616 O
and 53 56 1617 1620 O
have 57 61 1621 1625 O
no 62 64 1626 1628 O
known 65 70 1629 1634 O
standard 71 79 1635 1643 O
curative 80 88 1644 1652 B-treatment
therapy 89 96 1653 1660 I-treatment

serum 0 5 1661 1666 B-clinical_variable
cholesterol 6 17 1667 1678 I-clinical_variable
≤ 18 19 1679 1680 O
300 20 23 1681 1684 B-upper_bound
mg 24 26 1685 1687 I-upper_bound
/ 26 27 1687 1688 I-upper_bound
dL 27 29 1688 1690 I-upper_bound

who 0 3 1691 1694 O
are 4 7 1695 1698 O
refractory 8 18 1699 1709 O
to 19 21 1710 1712 O
front 22 27 1713 1718 B-treatment
- 27 28 1718 1719 I-treatment
line 28 32 1719 1723 I-treatment
therapy 33 40 1724 1731 I-treatment

